Business Context and Reporting Period
Company: MiMedx Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 2, 2018
Context: The filing addresses a regulatory compliance issue regarding the company's stock listing status on the Nasdaq stock exchange.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing compliance notice rather than financial performance data.
Material Changes
- Listing Status: On March 2, 2018, the Company received notice from Nasdaq that its common stock no longer complies with Listing Rule 5250(c)(1).
- Reason for Non-Compliance: The Company has not yet filed its Annual Report on Form 10-K.
Outlook, Management Commentary, and Risks
- Compliance Plan: The Company intends to submit a plan to regain compliance within 60 days of the notice.
- Extension Possibility: Nasdaq may grant an exception allowing the Company to remain listed for up to 180 calendar days from the Form 10-K due date, extending until August 28, 2018, if the plan is accepted.
- Disclosure: A press release regarding these matters was issued and is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the current status of the Company's Form 10-K filing.
- Confirm whether the Company has submitted a compliance plan to Nasdaq within the 60-day window.
- Monitor Nasdaq's decision on whether to grant the 180-day extension for continued listing.
- Review the press release (Exhibit 99.1) for additional management commentary on the delay.